Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese Males

Summary

This is a study of GAP-134, an antiarrhythmic di-peptide. This study will provide an initial assessment of the safety, tolerability, and pharmacokinetics (PK) of GAP-134 after administration of ascending single intravenous (IV) doses to healthy Japanese male subjects.

Timeline

Start

2007-10

Primary completion

2008-03

Completion

2008-03

Drugs

Indications